Home › Insulin Resistance › Maryland
Pag-aaral pangklinika para sa Insulin Resistance sa Maryland
7 pag-aaral para sa Insulin Resistance ang naghahanap ng mga kalahok sa mga site sa Maryland.
Mga Lungsod sa Maryland
Opisyal na teksto ng pag-aaral (English)
Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial
- National Institute of Aging, Clinical Research Unit, Baltimore
Nagre-recruit
Edad 55 hanggang 100 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06274749Tirzepatide for Treatment of CCCA
- Johns Hopkins Outpatient Center, Baltimore
- Medical Pavilion at Howard County, Columbia
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07734870Taste Bud-Derived Stem Cells in Humans
- National Institute of Aging, Clinical Research Unit, Baltimore
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT03366168Risk-informed Shared-decision Making Engagement Strategy for Patients With Prediabetes
- Johns Hopkins Community Physicians Frederick, Frederick
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07553325Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Baltimore VA Medical Center Univ of Maryland, Baltimore
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07599982Genetic Studies of Insulin and Diabetes
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
6 Months – 120 Years · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT00001987Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT05470504Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.